<i>Efficacy of Danlou Tablet</i> in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial

<div>UPLC fingerprints of 15 batches of Danlou Tablets. 2: 5-hydroxymethyl furfural; 3: danshensu; 5: puerarin; 9: daidzin; 11: Sal B; 13: Sal A; and 15: tanshinone II A.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: <i>Efficacy of Danlou Tablet</i> in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial 

Figure 1 | Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial 